NM_173628.4:c.4564G>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_173628.4(DNAH17):​c.4564G>T​(p.Asp1522Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.136 in 1,612,306 control chromosomes in the GnomAD database, including 15,983 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1228 hom., cov: 33)
Exomes 𝑓: 0.14 ( 14755 hom. )

Consequence

DNAH17
NM_173628.4 missense

Scores

13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.787

Publications

14 publications found
Variant links:
Genes affected
DNAH17 (HGNC:2946): (dynein axonemal heavy chain 17) Dyneins are microtubule-associated motor protein complexes composed of several heavy, light, and intermediate chains. DNAH17 is a heavy chain associated with axonemal dynein (Milisav and Affara, 1998 [PubMed 9545504]).[supplied by OMIM, Mar 2008]
DNAH17 Gene-Disease associations (from GenCC):
  • spermatogenic failure 39
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • non-syndromic male infertility due to sperm motility disorder
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024757385).
BP6
Variant 17-78507478-C-A is Benign according to our data. Variant chr17-78507478-C-A is described in ClinVar as Benign. ClinVar VariationId is 402689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.153 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH17NM_173628.4 linkc.4564G>T p.Asp1522Tyr missense_variant Exon 28 of 81 ENST00000389840.7 NP_775899.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH17ENST00000389840.7 linkc.4564G>T p.Asp1522Tyr missense_variant Exon 28 of 81 5 NM_173628.4 ENSP00000374490.6
DNAH17ENST00000587177.1 linkn.616G>T non_coding_transcript_exon_variant Exon 2 of 7 5

Frequencies

GnomAD3 genomes
AF:
0.111
AC:
16936
AN:
152166
Hom.:
1230
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0293
Gnomad AMI
AF:
0.0976
Gnomad AMR
AF:
0.137
Gnomad ASJ
AF:
0.162
Gnomad EAS
AF:
0.0653
Gnomad SAS
AF:
0.0871
Gnomad FIN
AF:
0.127
Gnomad MID
AF:
0.165
Gnomad NFE
AF:
0.155
Gnomad OTH
AF:
0.129
GnomAD2 exomes
AF:
0.132
AC:
32907
AN:
248942
AF XY:
0.133
show subpopulations
Gnomad AFR exome
AF:
0.0271
Gnomad AMR exome
AF:
0.164
Gnomad ASJ exome
AF:
0.167
Gnomad EAS exome
AF:
0.0672
Gnomad FIN exome
AF:
0.125
Gnomad NFE exome
AF:
0.156
Gnomad OTH exome
AF:
0.148
GnomAD4 exome
AF:
0.139
AC:
202342
AN:
1460022
Hom.:
14755
Cov.:
64
AF XY:
0.138
AC XY:
100381
AN XY:
725940
show subpopulations
African (AFR)
AF:
0.0247
AC:
825
AN:
33462
American (AMR)
AF:
0.163
AC:
7284
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.166
AC:
4328
AN:
26126
East Asian (EAS)
AF:
0.0579
AC:
2294
AN:
39636
South Asian (SAS)
AF:
0.0911
AC:
7855
AN:
86224
European-Finnish (FIN)
AF:
0.127
AC:
6778
AN:
53386
Middle Eastern (MID)
AF:
0.153
AC:
881
AN:
5764
European-Non Finnish (NFE)
AF:
0.148
AC:
164156
AN:
1110422
Other (OTH)
AF:
0.132
AC:
7941
AN:
60324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
11447
22894
34340
45787
57234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5620
11240
16860
22480
28100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.111
AC:
16935
AN:
152284
Hom.:
1228
Cov.:
33
AF XY:
0.109
AC XY:
8134
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0293
AC:
1217
AN:
41576
American (AMR)
AF:
0.136
AC:
2087
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.162
AC:
563
AN:
3468
East Asian (EAS)
AF:
0.0655
AC:
339
AN:
5178
South Asian (SAS)
AF:
0.0871
AC:
421
AN:
4832
European-Finnish (FIN)
AF:
0.127
AC:
1349
AN:
10610
Middle Eastern (MID)
AF:
0.170
AC:
50
AN:
294
European-Non Finnish (NFE)
AF:
0.155
AC:
10551
AN:
68010
Other (OTH)
AF:
0.127
AC:
269
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
780
1560
2340
3120
3900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
204
408
612
816
1020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.137
Hom.:
3512
Bravo
AF:
0.109
TwinsUK
AF:
0.147
AC:
546
ALSPAC
AF:
0.145
AC:
560
ESP6500AA
AF:
0.0258
AC:
108
ESP6500EA
AF:
0.148
AC:
1256
ExAC
AF:
0.130
AC:
15686
Asia WGS
AF:
0.0710
AC:
247
AN:
3478
EpiCase
AF:
0.166
EpiControl
AF:
0.158

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

DNAH17-related disorder Benign:1
Oct 29, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
0.22
DANN
Benign
0.53
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.069
N
LIST_S2
Benign
0.80
T;T
MetaRNN
Benign
0.0025
T;T
MetaSVM
Benign
-1.1
T
PhyloP100
-0.79
PrimateAI
Benign
0.25
T
REVEL
Benign
0.031
Vest4
0.35
ClinPred
0.00072
T
GERP RS
-3.3
Varity_R
0.050
gMVP
0.47
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62073553; hg19: chr17-76503560; COSMIC: COSV67751003; COSMIC: COSV67751003; API